Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
CONCLUSIONS: We conclude that neither diabetes diagnosis nor metformin use is associated with a difference in oncotype RS in this population of diabetic patients.
PMID: 32182614 [PubMed - as supplied by publisher]
Source: Oncology - Category: Cancer & Oncology Authors: Tharakan S, Zimmerman B, Ru M, Blanter J, Cascetta K, Tiersten A Tags: Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Hormones | Metformin | Statistics | Study | Switzerland Health | Tamoxifen